An evaluation of the trimmed mean approach in clinical trials with dropout.
- Published in:
- Pharmaceutical Statistics, 2018, v. 17, n. 3, p. 278, doi. 10.1002/pst.1858
- By:
- Publication type:
- Article
Works matching IS 1539-1604 AND VI 17 AND IP 3 AND DT 2018
Results: 7
1
2
CORRIGENDUM: Equal-tailed confidence intervals for comparison of rates.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
3
Estimating the variance for heterogeneity in arm-based network meta-analysis.
- Published in:
- Pharmaceutical Statistics, 2018, v. 17, n. 3, p. 264, doi. 10.1002/pst.1857
- By:
- Publication type:
- Article
4
Approaches to sample size calculation for clinical trials in rare diseases.
- Published in:
- Pharmaceutical Statistics, 2018, v. 17, n. 3, p. 214, doi. 10.1002/pst.1848
- By:
- Publication type:
- Article
5
Longitudinal assessment of the impact of multiple switches between a biosimilar and its reference product on efficacy parameters.
- Published in:
- Pharmaceutical Statistics, 2018, v. 17, n. 3, p. 231, doi. 10.1002/pst.1849
- By:
- Publication type:
- Article
6
Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time-to-event end point.
- Published in:
- Pharmaceutical Statistics, 2018, v. 17, n. 3, p. 202, doi. 10.1002/pst.1846
- By:
- Publication type:
- Article
7
Bayesian joint modelling of benefit and risk in drug development.
- Published in:
- Pharmaceutical Statistics, 2018, v. 17, n. 3, p. 248, doi. 10.1002/pst.1852
- By:
- Publication type:
- Article